Investigators found that the adjusted mean change in A1C was –0.62% for dapagliflozin compared to 0.41% for a placebo in patients with type 2 diabetes.
New coverage expansions to benefit Type 2 Diabetes patients merrittherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from merrittherald.com Daily Mail and Mail on Sunday newspapers.
Expanded coverage is now available to British Columbians being treated for Type 2 diabetes, heart failure and blood clots, the provincial Health Ministry says.
AstraZeneca Pharma India Ltd has received an Import and Market permission in Form CT-20 from the CDSCO , Directorate General of Health Services, Government of India for Dapagliflozin i.e., Forxiga® tablets of 10 mg - additional indication.
New PBS listing: Dapagliflozin for chronic kidney disease nps.org.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nps.org.au Daily Mail and Mail on Sunday newspapers.